Chulalongkorn University’s Centre of Excellence in Vaccine Research and Development expects to register its mRNA Covid-19 vaccine, known as ChulaCOV-19, mid-next year.

Kiat Raxrungtham, head of the Covid-19 vaccine development project, said ChulaCov-19 is about to enter its third phase of human trials with jabs scheduled to be administered early next year to March.

Full story: Bangkok Post

BANGKOK POST REPORTERS